期刊文献+

多西他赛联合洛铂治疗乳腺癌15例近期疗效分析 被引量:2

下载PDF
导出
摘要 目的:探讨多西他赛联合洛铂每3周给药方案,治疗乳腺癌的疗效及毒副反应。方法:对乳腺癌15例患者用多西他赛80 mg/m2联合洛铂35 mg/m2,第1天给药方案治疗。每3周重复,至少完成3周期。结果:乳腺癌15例完全缓解2例,分缓解7例,稳定2例,进展1例,总有效9例(60.0%)。Ⅲ~Ⅳ度的中性粒细胞减少发生5例(33.3%),Ⅲ~Ⅳ度血小板减少发生3例(20.0%),非血液学毒性以疲劳乏力为主。结论:多西他赛联合洛铂治疗乳腺癌是安全有效的。
出处 《南通大学学报(医学版)》 2008年第3期233-,235,共2页 Journal of Nantong University(Medical sciences)
  • 相关文献

参考文献4

二级参考文献23

  • 1[1]Jamieson ER,Lippard SJ.Structure,recognition,and processing of cisplatin-DNA adducts[J].Chem Rev,1999,99(9):2467-2498.
  • 2[2]Galanski M,Jakupec MA,Keppler BK.Update of the preclinical situation of anticancer platinum complexes:novel design strategies and innovative analytical approaches[J].Curr Med Chem,2005,12(18):2075-2094.
  • 3[4]Sternburg CN,De mulder P,Fossa S,et al.Lobaplatin in advanced urothelial tract tumors.the genitourinary group of the european organization for research and treatment of cancer (EORTC)[J].Ann Oncol.1997,8(7):695-696.
  • 4Hanauske AR, Degen D, Hilsenbeck SG, et al. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anticancer Drugs, 1992, 3:121-124.
  • 5Kelland LR, Abel G. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol, 1992, 30:444-450.
  • 6Figgitt DP, Wiseman LR. Docetaxel: an update of its use in advanced breast cancer. Drugs, 2000, 59:621-651.
  • 7Sparano JA. Taxanes for breast cancer: an evidence-based review of randomized phase Ⅱ and phase Ⅲ trials. Clin Breast Cancer, 2000,1 : 32-40.
  • 8Fulton B, Spencer CM. Docetaxel : a review of its pharmaeodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer. Drugs, 1996, 51 : 1075-1092.
  • 9Kruijtzer CMF, Verweij J, Schellens JH, et al. Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: results of a compassionate use program in The Netherlands. Anticancer Drugs, 2000, 11:249-255.
  • 10Brodowicz T, Koestler WJ, Tomek S, et al. Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer. Anticancer Drugs, 2000, 11:149-153.

共引文献138

同被引文献37

引证文献2

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部